Applicant, as named in the Orange Book

Thea Pharma

Next listed expiry: Zioptan on 28 May 2029. 3 products with live protection, 5 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Zioptan tafluprost	tafluprost	202514	28 May 2029	patent
Iyuzeh latanoprost	latanoprost	216472	8 Jul 2031	patent
Zolymbus bimatoprost	bimatoprost	217307	8 Jun 2036	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products without listed protection (5)

Drug	Ingredient	NDA	Earliest generic entry	Basis
Akten lidocaine hydrochloride	lidocaine hydrochloride	022221	open now	no listed protection
Azasite azithromycin	azithromycin	050810	open now	no listed protection
Betimol timolol	timolol	020439	open now	no listed protection
Cosopt dorzolamide hydrochloride; timolol maleate	dorzolamide hydrochloride; timolol maleate	020869	open now	no listed protection
Cosopt Pf dorzolamide hydrochloride; timolol maleate	dorzolamide hydrochloride; timolol maleate	202667	open now	no listed protection